Endometrioid carcinomas of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features: A report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms

American Journal of Surgical Pathology

Volumn 29, Issue 2, 2005, Pages 157-166

  Murray, Shawn K ^a,d   Clement, Philip B ^b   Young, Robert H ^c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d DJ Mackenzie Building 736 ^*  (Canada)

Author keywords

Endometrioid carcinoma; Hyalinization; Sex cord like formations; Uterine corpus

Indexed keywords

ALPHA ACTIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; DESMIN; INHIBIN; KERATIN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CARCINOSARCOMA; CLINICAL ARTICLE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; EPITHELIOID CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OSTEOID; PROGNOSIS; SEX CORD TUMOR; SPINDLE CELL; UTERUS CANCER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; CARCINOSARCOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROGNOSIS; UTERINE NEOPLASMS;

EID: 12844255771     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000149704.89463.05     Document Type: Article

References (52)

1. Ali S, Wells M. Mixed mullerian tumors of the uterine corpus: a review. Int J Gynecol Cancer. 1993;3:1-11.
2. Auerbach HE, LiVolsie VA, Merino MJ. Malignant mixed Mullerian tumors of the uterus: an immunohistochemical study. Int J Gynecol Pathol. 1988;7:123-130.
3. Baker RJ, Hildebrandt RH, Rouse RV. Inhibin and CD99 (MIC2) expression in uterine stromal neoplasms with sex-cord-like elements. Hum Pathol. 1999;30:671-679.
4. Barwick KW, LiVolsi VA. Malignant mixed mullerian tumors of the uterus. Am J Surg Pathol. 1979;3:125-135.
5. Bitterman P, Chun B, Kurman RJ. The significance of epithelial differentiation in mixed mesodermal tumors of the uterus: a clinicopathologic and immunohistochemical study. Am J Surg Pathol. 1990;14:317-328.
6. Blom R, Guerrieri C, Stal O, et al. Malignant mixed Mullerian tumors of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 44 cases. Gynecol Oncol. 1998;68:18-24.
7. Chang KL, Crabtree GS, Lim-Tam SK. Primary uterine endometrial stromal neoplasms: a clinicopathologic study of 117 cases. Am J Surg Pathol. 1990;14:415-438.
8. Chu PG, Arber DA, Weiss LM, et al. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases. Mod Pathol. 2001;14:465-471.
9. Chuang JT, Van Velden DJ, Graham JB. Carcinosarcoma and mixed mesodermal tumor of the uterine corpus: review of 49 cases. Obstet Gynecol. 1970;35:769-780.
10. Clement PB, Scully RE. Endometrial stromal sarcomas of the uterus with extensive endometrial glandular differentiation: a report of three cases that caused problems in differential diagnosis. Int J Gynecol Pathol. 1992;11:163-173.
11. Clement PB, Scully RE. Mullerian adenosarcoma of the uterus: a clinicopathological analysis of 100 cases with a review of the literature. Hum Pathol. 1990;21:363-381.
12. Clement PB, Scully RE. Mullerian adenosarcomas of the uterus with sex cord-like elements: a clinicopathological analysis of eight cases. Am J Clin Pathol. 1989;91:664-672.
13. Clement PB, Scully RE. Uterine tumors resembling ovarian sex-cord tumors: a clinicopathologic analysis of fourteen cases. Am J Clin Pathol. 1976;66:512-525.
14. Clement PB, Scully RE. Uterine tumors with mixed epithelial and mesenchymal elements. Semin Diagn Pathol. 1988;5:199-222.
15. Clement PB, Young RH. Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects. Adv Anal Pathol. 2002;9:145-184.
16. Costa MJ, Khan R, Judd R. Carcinosarcoma (malignant mixed mullerian [mesodermal] tumor) of the uterus and ovary: correlation of clinical, pathologic, and immunohistochemical features in 29 cases. Arch Pathol Lab Med. 1991;115:583-590.
17. Daya D, Young RH, Scully RE. Endometrioid carcinoma of the fallopian tube resembling an adnexal tumor of probable Wolffian origin: a report of six cases. Int J Gynecol Pathol. 1992;11:122-130.
18. de Brito PA, Silverberg SG, Orenstein JM. Carcinosarcoma (malignant mixed mullerian (mesodermal) tumor) of the female genital tract: immunohistochemical and ultrastructural analysis of 28 cases. Hum Pathol. 1993; 24:132-142.
19. Doss LL, Llorens AS, Henriquez EM. Carcinosarcoma of the uterus: a 40-year experience from the state of Missouri. Gynecol Oncol. 1984;18: 43-53.
20. Eichhorn JH, Young RH, Clement PB. Sertoliform endometrial adenocarcinoma: a study of four cases. Int J Gynecol Pathol. 1996;15:119-126.
21. Gagne E, Tetu B, Blondeau L, et al. Morphologic prognostic factors of malignant mixed mullerian tumor of the uterus: a clinicopathologic study of 58 cases. Mod Pathol. 1989;2:433-438.
22. George E, Lillemoe TJ, Twiggs LB, et al. Malignant mixed mullerian tumor versus high-grade endometrial carcinoma and aggressive variants of endometrial carcinoma: a comparative analysis of survival. Int J Gynecol Pathol. 1995;14:39-44.
23. George E, Manivel JC, Dehner LP, et al. Malignant mixed mullerian tumors: an immunohistochemical study of 47 cases, with histogenetic considerations and clinical correlation. Hum Pathol. 1991;22:215-223.
24. Guerrieri C, Franlund B, Malmstrom H, et al. Ovarian endometrioid carcinomas simulating sex cord-stromal tumors: a study using inhibin and cytokeratin 7. Int J Gynecol Pathol. 1998;17:266-271.
25. Iwasa Y, Haga H, Honishi I, et al. Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients. Cancer. 1998;82: 512-519.
26. Krishnamurthy S, Jungbluth AA, Busam KJ, et al. Uterine tumors resembling ovarian sex-cord tumors have an immunophenotype consistent with true sex-cord differentiation. Am J Surg Pathol. 1998;22:1078-1982.
27. Lillemoe TJ, Perrone T, Morris HJ, et al. Myogenous phenotype of epithelial-like areas in endometrial stromal sarcomas. Arch Pathol Lab Med. 1991;115:215-219.
28. Loddenkemper C, Mechsner S, Foss HD, et al. Use of oxytocin receptor expression in distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma. Am J Surg Pathol. 2003;27:1458-1462.
29. Lotocki R, Rosenhein NB, Grumbine F, et al. Mixed mullerian tumors of the uterus: clinical and pathologic correlations. Int J Obstet Gynecol. 1982;20:237-243.
30. Macasaet MA, Waxman M, Fruchter RG. Prognostic factors in malignant mesodermal (Mullerian) mixed tumors of the uterus. Gynecol Oncol. 1985;20:32-42.
31. Matadial L, Escoffery CT, Bowen-Chatoor JS. Sertoliform variant of endometrioid carcinoma of the ovary. West Indian Med J. 1995;44:72-73.
32. McCarroll AM, Montgomer DA, Harley JM. Endometrial carcinoma after cyclical oestrogen-progestogen therapy for Turner's syndrome. Br J Obstet Gynaecol. 1975;82:421-423.
33. McCluggage WG, Oliva E, Herrington CS, et al. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma. Histopathology. 2003;43:144-150.
34. McCluggage WG, Sumathi VP, Maxell P. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms. Histopathology. 2001;39:273-278.
35. Meis JM, Lawrence WD. The immunohistochemical profile of malignant mixed mullerian tumor: overlap with endometrial adenocarcinoma. Am J Clin Pathol. 1990;94:1-7.
36. Navani SS, Alvarado-Cabrero I, Young RH, et al. Endometrioid carcinoma of the fallopian tube: a clinicopathologic analysis of 26 cases. Gynecol Oncol. 1996;63:371-378.
37. Nogales F, Gomez-Morales M, Raymundo C, et al. Benign heterologous tissue components associated with endometrial carcinoma. Int J Gynecol Pathol. 1982;1:286-291.
38. Oliva E, Clement PB, Young RH, et al. Mixed endometrial stromal and smooth muscle tumors of the uterus: a clinicopathologic study of 15 cases. Am J Surg Pathol. 1998;22:997-1005.
39. Oliva E, Young RH, Clement PB, et al. Myxoid and fibrous endometrial stromal tumors of the uterus: a report of ten cases. Int J Gynecol Pathol. 1999;18:310-319.
40. Peters WA, Kumar NB, Fleming WP, et al. Prognostic features of sarcomas and mixed tumors of the endometrium. Obstet Gynecol. 1984;63:550-556.
41. Ramadan J, Goudie RB. Epithelial antigens in malignant mixed Mullerian tumours of endometrium. J Pathol. 1986;148:13-18.
42. Remadi S, Ismail A, Tawil A, et al. Ovarian sertoliform endometrioid carcinoma. Virchows Arch. 1995;426:533-536.
43. Roth LM, Liban E, Czernobilsky B. Ovarian endometrioid tumors mimicking Sertoli and Sertoli-Leydig cell tumors: sertoliform variant of endometrioid carcinoma. Cancer. 1982;50:1322-1331.
44. Silverberg SG, Major FJ, Blessings JA. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus: a Gynecologic Oncology Group pathologic study of 203 cases. Int J Gynecol Pathol. 1990;9:1-19.
45. Spanos WJ, Wharton JT, Gomez L, et al. Malignant mixed mullerian tumors of the uterus. Cancer. 1984;53:311-316.
46. Swisher EM, Gown AM, Skelly M, et al. The expression of epidermal growth factor receptor, HER-2/Neu, p53, and Ki-67 antigen in uterine malignant mesodermal tumors and adenosarcoma. Gynecol Oncol. 1996; 60:81-88.
47. Tornos C, Silva EG, Ordonez NG, et al. Endometrioid carcinoma of the ovary with a prominent spindle-cell component, a source of diagnostic confusion: a report of 14 cases. Am J Surg Pathol. 1995;19:1343-1353.
48. Usadi RS, Bentley RC. Endometrioid carcinoma of the endometrium with sertoliform differentiation. Int J Gynecol Pathol. 1995;14:360-364.
49. Yilmaz A, Rush DS, Soslow RA. Endometrial stromal sarcomas with unusual histologic features: a report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation. Am J Surg Pathol. 2002;26:1142-1150.
50. Young RH, Prat J, Scully RE. Ovarian endometrioid carcinomas resembling sex cord-stromal tumors: a clinicopathological analysis of 13 cases. Am J Surg Pathol. 1982;6:513-522.
51. Zaino RJ, Kurman RJ, Diana KL, et al. The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system: a Gynecologic Oncology Group study. Cancer. 1995;75:81-86.
52. Zaino RJ, Silverberg SG, Norris HJ, et al. The prognostic value of nuclear versus architectural grading in endometrial adenocarcinoma: a Gynecologic Oncology Group study. Int J Gynecol Pathol. 1994;13:29-36.